☆ 4.4 Article

What helps define outcomes in persistent uninterpretable non-invasive prenatal testing: Maternal factors, fetal fraction or quality scores?

PRENATAL DIAGNOSIS (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

White blood cell count affects fetal fraction and test failure rates in noninvasive prenatal screening

Longwei Qiao et al.

Summary: Increased white blood cell (WBC) count is associated with lower fetal fraction (FF) and higher test failure rates in noninvasive prenatal screening (NIPS). This study found that WBC count negatively correlated with FF and positively correlated with BMI, alanine aminotransferase (ALT), IVF conceptions, and gestational age. High WBC count significantly increased the risk of test failure. These findings highlight the importance of considering WBC count in genetic counseling for pregnant women.

FRONTIERS IN MEDICINE (2023)

Add to Collection

Article Obstetrics & Gynecology

Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results

Mary E. Norton et al.

Summary: The study aimed to assess the outcomes of pregnancies with nonreportable cell-free DNA screening. The results showed that patients with nonreportable results are at higher risk for adverse outcomes, including aneuploidy, preeclampsia, and preterm birth. Therefore, they should be offered diagnostic genetic testing, and clinicians should be aware of the increased risk of pregnancy complications.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

Prevalence of autoimmune disease among pregnant women and women of reproductive age in New South Wales, Australia: a population-based study

Timothy C. Nielsen et al.

Summary: The prevalence of autoimmune diseases among reproductive age and pregnant women is increasing in New South Wales, which may impact their health outcomes.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Add to Collection

Review Pediatrics

Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review

Cechuan Deng et al.

Summary: A paradigm shift has occurred in noninvasive prenatal screening with the discovery of cell-free fetal DNA in maternal plasma. Fetal fraction, an important parameter in analyzing screening results, combines biological factors and bioinformatics algorithms. This review aims to provide a deeper understanding of the significance, influencing factors, and interpretation of fetal fraction.

FRONTIERS IN PEDIATRICS (2022)

Add to Collection

Article Medicine, General & Internal

Lipid Metabolism Affects Fetal Fraction and Screen Failures in Non-invasive Prenatal Testing

Jun Cao et al.

Summary: This study found that lipid metabolism is associated with fetal fraction and the rate of screen failures in non-invasive prenatal testing (NIPT). Increased levels of low-density lipoprotein cholesterol and triglycerides were negatively associated with fetal fraction, while high-density lipoprotein cholesterol and the interval between tests were positively correlated with fetal fraction. In addition, high triglyceride levels were independently associated with an increased risk of screen failures.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Genetics & Heredity

Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study

Lisanne van Prooyen Schuurman et al.

Summary: The TRIDENT-2 study examines the clinical impact of genome-wide non-invasive prenatal testing (GW-NIPT) in pregnant women. The study found that additional findings were detected in 0.36% of pregnancies, with most fetal chromosomal abnormalities associated with severe clinical phenotypes. Cases with confined placental mosaicism (CPM) showed increased rates of pre-eclampsia and low birth weight. Maternal findings mainly included malignancies and pathogenic copy number variants.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Add to Collection

Article Medicine, General & Internal

The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures

Ping Chen et al.

Summary: The study aimed to determine the effects of alanine transaminase (ALT) levels on non-invasive prenatal screening (NIPS) failure rates or no calls due to low fetal fraction (FF). Results showed that increased ALT levels, body mass index, prealbumin, albumin levels, and in vitro fertilization (IVF) conception rates were associated with screening failures. Adjusting these factors may be significant in reducing the probability of no calls due to low FF in NIPS.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Genetics & Heredity

Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy

Samantha Caldwell et al.

Summary: This study found that low fetal fraction (FF) cfDNA failures do not necessarily indicate an increased risk of fetal aneuploidy or adverse pregnancy outcomes. Redrawing may be a suitable next step, as proceeding directly with diagnostic testing for aneuploidy may be unwarranted for most patients.

PRENATAL DIAGNOSIS (2021)

Add to Collection

Letter Obstetrics & Gynecology

Obesity and no-call results: optimal timing of cell-free DNA testing and redraw

Maeve K. Hopkins et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Review Genetics & Heredity

Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review

Peter G. Scheffer et al.

Summary: Low fetal fraction (LFF) in prenatal cell-free DNA (cfDNA) testing may indicate early abnormal placentation and is associated with adverse pregnancy outcomes. Studies have shown associations between LFF and pregnancy-related hypertensive disorders, restricted fetal growth, and preterm birth. Further large prospective cohort studies are needed to explore the relationship between fetal fraction and pregnancy outcomes due to limited available evidence.

PRENATAL DIAGNOSIS (2021)

Add to Collection

Article Genetics & Heredity

Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study

Ellis C. Becking et al.

Summary: The study found an association between low fetal fraction in prenatal cfDNA testing and adverse pregnancy outcomes, with higher risks of pregnancy-induced hypertension, pre-eclampsia, small for gestational age neonates, and gestational diabetes mellitus in the low fraction group. Further validation is needed to establish the predictive value of low fetal fraction for these outcomes.

PRENATAL DIAGNOSIS (2021)

Add to Collection

Article Obstetrics & Gynecology

Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium

Ana Dubon Garcia et al.

Summary: The study assessed the cost-effectiveness of the FMF screening algorithm for pre-term PE in nulliparous women in Belgium. Results showed that the FMF algorithm led to fewer cases of pre-term PE and cost savings compared to the SOC, with similar impact on quality-adjusted life-years. The FMF screening algorithm was cost-saving and more effective in 99.4% of simulations.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2021)

Add to Collection

Article Health Care Sciences & Services

International versus national growth charts for identifying small and large-for-gestational age newborns: A population-based study in 15 European countries

Alice Hocquette et al.

Summary: The study compared perinatal mortality rates for small and large-for-gestational-age infants in Europe according to international and national growth charts. The findings suggest that using international charts in Europe could lead to growth restricted infants being reclassified as normal growth and infants with low mortality risks being classified as excessive growth.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Obstetrics & Gynecology

The impact of maternal autoimmune disease on cell-free DNA test characteristics

Hayley J. MacKinnon et al.

Summary: This study found that women with autoimmune diseases have lower fetal cell-free DNA fractions and higher rates of indeterminate results compared to women without autoimmune diseases, with no difference in total cell-free DNA concentration. Treatment with immunomodulator therapy may decrease the rate of indeterminate results.

AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM (2021)

Add to Collection

Review Obstetrics & Gynecology

Prevalence of autoimmune conditions in pregnant women in a tertiary maternity hospital: A cross-sectional survey and maternity database review

Jacqueline R. Lim et al.

Summary: The prevalence of autoimmune diseases in pregnant women may be higher than previously reported, as indicated by a survey and review of hospital databases. Self-reported prevalence was found to be higher than estimates based solely on administrative data.

OBSTETRIC MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies

Liesbeth Lenaerts et al.

Summary: This study evaluated the positive predictive value of NIPT results and found a new approach with high accuracy for cancer detection. Effective management of these cases can be achieved through multidisciplinary clinical follow-up.

ECLINICALMEDICINE (2021)

Add to Collection

Article Genetics & Heredity

Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening

Herman Hedriana et al.

PRENATAL DIAGNOSIS (2020)

Add to Collection

Article Genetics & Heredity

Association between cell-free DNA fetal fraction and gestational diabetes

Maeve K. Hopkins et al.

PRENATAL DIAGNOSIS (2020)

Add to Collection

Article Obstetrics & Gynecology

Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation

Kasper Gadsboll et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)

Add to Collection

Review Obstetrics & Gynecology

Noninvasive prenatal testing and maternal obesity: A review

Laura A. Juul et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)

Add to Collection

Article Obstetrics & Gynecology

Fetal Fraction and Noninvasive Prenatal Testing

Lisa Hui et al.

OBSTETRICAL & GYNECOLOGICAL SURVEY (2020)

Add to Collection

Article Obstetrics & Gynecology

Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes

Xiaosong Yuan et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2020)

Add to Collection

Article Genetics & Heredity

Effects of medication intake in early pregnancy on the fetal fraction of cell-free DNA testing

Maggie Kuhlmann-Capek et al.

PRENATAL DIAGNOSIS (2019)

Add to Collection

Article Acoustics

First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure

S. Galeva et al.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)

Add to Collection

Article Genetics & Heredity

TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands

Karuna R. M. van der Meij et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2019)

Add to Collection

Review Genetics & Heredity

Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results

Diana W. Bianchi

GENETICS IN MEDICINE (2018)

Add to Collection

Article Genetics & Heredity

Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study

Diane Van Opstal et al.

GENETICS IN MEDICINE (2018)

Add to Collection

Article Acoustics

Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting

C. B. Miltoft et al.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)

Add to Collection

Article Acoustics

Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia

D. L. Rolnik et al.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)

Add to Collection

Editorial Material Obstetrics & Gynecology

Implications of Failure to Achieve a Result From Prenatal Maternal Serum Cell-Free DNA Testing: A Historical Cohort Study

[Anonymous]

OBSTETRICAL & GYNECOLOGICAL SURVEY (2018)

Add to Collection

Article Genetics & Heredity

The clinical utility of genome-wide non invasive prenatal screening

Francesco Fiorentino et al.

PRENATAL DIAGNOSIS (2017)

Add to Collection

Article Obstetrics & Gynecology

Obesity and cell-free DNA no calls: is there an optimal gestational age at time of sampling?

Mary C. Livergood et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)

Add to Collection

Review Genetics & Heredity

Clinical implementation of NIPT - technical and biological challenges

P. Brady et al.

CLINICAL GENETICS (2016)

Add to Collection

Review Immunology

Pregnancy in patients with autoimmune disease: A reality in 2016

A. Tincani et al.

AUTOIMMUNITY REVIEWS (2016)

Add to Collection

Article Genetics & Heredity

Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing

Iris Krishna et al.

PRENATAL DIAGNOSIS (2016)

Add to Collection

Review Genetics & Heredity

The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon

Yuval Yaron

PRENATAL DIAGNOSIS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management

Baran Bayindir et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2015)

Add to Collection

Article Genetics & Heredity

Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts

Sung K. Kim et al.

PRENATAL DIAGNOSIS (2015)

Add to Collection

Article Genetics & Heredity

Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing

Sarah L. Kinnings et al.

PRENATAL DIAGNOSIS (2015)

Add to Collection

Review Developmental Biology

Review: Cell-free fetal DNA in the maternal circulation as an indication of placental health and disease

E. S. Taglauer et al.

PLACENTA (2014)

Add to Collection

Article Multidisciplinary Sciences

Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing

Rebecca W. Y. Chan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Add to Collection

Article Acoustics

Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics

G. Ashoor et al.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2013)

Add to Collection

Article Endocrinology & Metabolism

Increased Death of Adipose Cells, a Path to Release Cell-Free DNA Into Systemic Circulation of Obese Women

Maricela Haghiac et al.

OBESITY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.